Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Circulating level of high mobility group box-1 predicts the severity of community-acquired pneumonia
 
  • Details
Options

Circulating level of high mobility group box-1 predicts the severity of community-acquired pneumonia

Other Title
Regulation of inflammatory responses via the c-Jun N-terminal signaling pathway in macrophages
Journal
Molecular Medicine Reports
Date Issued
2017-09-01
Author(s)
CHAO-BIN YEH  
YING-ERH CHOU  
SHUN-FA YANG  
DOI
10.3892/mmr.2017.6892
URI
https://www.scopus.com/pages/publications/85025709022
https://scholars.csmu.edu.tw/handle/123456789/23736
Abstract
High mobility group box-1 (HMGB-1) has been reported to serve significant roles in various inflammatory diseases. However, the correlation between the circulating level of HMGB-1 and severity of community-acquired pneumonia (CAP) remains unclear. The present study investigated differential alterations in plasma HMGB-1 levels of patients with CAP prior to and following antibiotic treatment, and further analyzed the association between CAP severity and HMGB-1 levels. Furthermore, lipopolysaccharide (LPS)-induced HMGB-1 expression in RAW264.7 macrophages and the relevant signaling pathways were examined. Plasma HMGB-1 levels of 90 patients with CAP and 52 healthy controls were measured using a commercial ELISA. The levels of plasma HMGB-1 were significantly elevated in CAP patients compared with the controls, and antibiotic treatment was effective in reducing HMGB-1 levels. Plasma HMGB-1 correlated with the pneumonia severity index score (r=0.566, P<0.001). Furthermore, LPS-stimulation significantly upregulated HMGB-1 secretion via the c-Jun N-terminal kinase (JNK) signaling pathway in RAW264.7 macrophages, whereas pretreatment with the JNK inhibitor SP600125 markedly downregulated LPS-induced HMGB-1 levels. In conclusion, plasma HMGB-1 levels may serve a role in the diagnosis and clinical assessment of CAP severity. These findings may provide information on novel targets for the treatment of CAP.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback